Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. - Wikidata - wikimedia - TriplyDB

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

http://www.wikidata.org/entity/Q37701353

about

Recent Advances in Subunit Vaccine Carriers Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform Biomimetic and synthetic interfaces to tune immune responses Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications Cell or cell membrane-based drug delivery systems The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery Synthetic Nanoparticles for Vaccines and Immunotherapy Engineering New Approaches to Cancer Vaccines Convergence of nanotechnology and cancer prevention: are we there yet?A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles Scanning electron microscopy image representativeness: morphological data on nanoparticles.Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome.Clearance of pathological antibodies using biomimetic nanoparticles.Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles In Vitro Administration of Gold Nanoparticles Functionalized with MUC-1 Protein Fragment Generates Anticancer Vaccine Response via Macrophage Activation and Polarization Mechanism.Modulating antibacterial immunity via bacterial membrane-coated nanoparticles Engineered nanoparticles mimicking cell membranes for toxin neutralization.Synthesis of Nanogels via Cell Membrane-Templated Polymerization.Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.Virus-mimetic nanovesicles as a versatile antigen-delivery system.Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer Cell membrane-camouflaged nanoparticles for drug delivery.Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers Coating nanofiber scaffolds with beta cell membrane to promote cell proliferation and function.Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.Bio-inspired virus-like nanovesicle for effective vaccination.Anticancer Platelet-Mimicking Nanovehicles.Internalized compartments encapsulated nanogels for targeted drug delivery.Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.Raspberry-like poly(γ-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs.Artificial cells: from basic science to applications.Antitumor Activities of Metal Oxide Nanoparticles.Protein bio-corona: critical issue in immune nanotoxicology.

P2860

Q26750929-6A75F253-86B8-4EB4-B947-DDF58E5B322A Q26782566-A8E9C7D6-F286-4BDB-9B7F-3DFCC5D21D3F Q26784233-89580EB4-91C5-469F-9A1B-CEC9122BE052 Q26801229-D579BBD9-62FB-4387-87D2-C8715230EB5A Q28076544-BF88DD6F-6673-42C8-A5E9-F9C0E818181D Q28080710-1770FF04-BB82-4DD1-BB2C-FD78A6C250BB Q28085280-DEBB6DC8-ADD6-4F85-81DE-53A65818485F Q28085375-6F5DE890-9397-492D-9EF7-273398D95406 Q28085563-BAAD6FB8-324E-4655-8F28-85A8D8709706 Q28386699-78F7C62E-5E19-4573-9C58-719400D89DB0 Q28833663-635A75EB-15EC-4250-AD67-8716BA842E82 Q31125128-E3780371-D385-4DFB-9F80-7797273B6851 Q33435943-237749EA-0C47-4FA4-9BFC-85572453282F Q33594253-466C1D0D-3F27-4A1B-B629-CDE330636898 Q33908373-E934CF01-A3FC-4637-BF4E-BCE1FB419CDE Q34218004-EF3F1A72-0684-4C89-A5B3-0DD64B02E6F0 Q34427093-773F2D43-1A7E-40EF-B048-55D74E3B6369 Q34477424-BFD4E419-6066-48BC-AC62-BC6383B18168 Q35447934-1A5AF9CA-7815-448E-A9CF-47E49CAA7F8C Q35991625-A0376CD9-F4A6-484F-91D4-6ACBC6B37D86 Q36037531-171E94B6-CA47-4B5E-9D56-E95E3C7C9B16 Q36170378-B2241A5C-C1BD-4AE5-A6F4-2A15A133FC23 Q36269694-F587C278-4F6A-4D42-8DB0-4039C3FB6E6C Q36296097-39FA5CFE-8855-4363-95FD-AF07BECD52D8 Q36300220-015D3D0E-A1AC-4CED-BBC1-B2CC36F6664C Q36329068-76F45EFB-7897-4E2F-BDA6-AE106A5E7AFC Q36396004-F538781D-B1C4-4D4F-AE70-C8312639D30A Q36461811-D7E692F4-B7F5-49B5-A560-F415EF385184 Q36801498-2C67B5C9-B610-4566-A516-BD8C04A95793 Q36900851-443202C0-9512-4B86-B0E5-AE2E877EE8B2 Q36926013-52CB128A-6DB7-4248-AA5A-CA50B5295D44 Q37016217-0241B34A-227D-4474-A2FE-3C93977D8364 Q37197146-E15DBD22-C8C2-4CF5-81AB-22B70F75F828 Q37206537-FACC4C18-E002-4431-B97F-88B214171469 Q37210607-ED3B1139-6FB1-4F89-876C-8386CA008A3A Q37357786-24E11879-8F6C-4269-876A-2B38D859400A Q37385216-3B4C445B-E19D-4A80-873B-C6F9AA34F5DD Q37574221-19FB43FF-7EB2-4ACD-A23E-3E34AF81F048 Q37646351-5AF0B6AC-C5E0-454C-BB72-E9204B33E6F1 Q37651354-2557DBDC-81A8-4C57-B7F6-995CF66CE967

P2860

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

http://www.wikidata.org/entity/Q37701353

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@en

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@nl

type

label

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@en

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@nl

prefLabel

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@en

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@nl

P1433

Q37701353-84135EC8-8494-4C1E-976A-D0B95163A08E

P1476

Q37701353-54381432-B2CD-4E1D-A639-5468F55927C8

P2093

Q37701353-4DCCF41A-FC33-4B61-80C9-B3880E076F97

Q37701353-6E67C8CD-B017-4F27-86F2-1A0F9486C052

Q37701353-7FCAEE13-AD94-421B-B87A-03C90CDEF264

Q37701353-B41FF215-27F6-48F6-86A7-3D60C2B80DD6

Q37701353-C52FFDB1-0344-4126-B732-8789DE8AE57F

Q37701353-D5134FB0-8FEC-4160-8EF2-0844AD1383F7

Q37701353-EA9DAF5A-1A6C-483C-828F-C9D9FBD0DA49

Q37701353-EDEB15AD-6792-41D8-A9CB-908C8CED5D2E

P2860

Q37701353-10E21C3D-B261-4046-9142-22FE96104F19

Q37701353-17F6D1C8-7857-490A-9770-68CFF1C77198

Q37701353-1E0F047B-79FC-4E1E-AE55-B99A33A51D9B

Q37701353-1ECAB278-5F9D-46F1-AC2A-CFD872C67F8A

Q37701353-2BDFB18F-CE56-4459-A69F-B6F268D3B3DE

Q37701353-2C23B7BB-F770-4225-BE69-F24A0157C267

Q37701353-2FFE5F98-9827-4EA1-BEE6-8D3D120D7A9F

Q37701353-32BFB900-E680-4732-B798-ABBAB0D1D975

Q37701353-3AB9BE0F-ADAD-4EE6-B3C0-1EF360FFC702

Q37701353-4470E9C3-C861-4900-AB1F-81E970208FC3

P304

Q37701353-369FC908-3E86-4797-94FB-71223399E84A

P31

Q37701353-40E9DAA1-8F79-4EB5-8614-76BD177F1D59

P356

Q37701353-A95D57F5-F8C2-43A2-B850-900C11420990

P407

Q37701353-2D9B5E03-3E57-494F-9ACF-13EE8716904C

P433

Q37701353-680E18B1-E8BE-4554-BDB2-DE8E96DEB7FC

P478

Q37701353-C9A75024-AA08-49FA-B2EF-0C9CA71090A8

P577

Q37701353-A0711188-3196-4C07-B2C5-6CBA9CB6AFD4

P5875

Q37701353-7D9B8869-7C7D-4F35-9396-E9EBB2E453A7

P698

Q37701353-2E731449-361B-4D30-A270-FB30E2177567

P921

Q37701353-07D0ECB5-AE31-42F3-A267-BC0F210538F7

Q37701353-A9EE2A68-4A66-42DC-B98B-1D2305E782D4

P932

Q37701353-EB19B9CA-A9EA-462A-93EC-D248F5E7475E

P356

P1433

P1476

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

@en

P2093

Brian T Luk

http://www.w3.org/2001/XMLSchema#string

Che-Ming J Hu

http://www.w3.org/2001/XMLSchema#string

Derek E O'Connor

http://www.w3.org/2001/XMLSchema#string

Jonathan A Copp

http://www.w3.org/2001/XMLSchema#string

Liangfang Zhang

http://www.w3.org/2001/XMLSchema#string

Ronnie H Fang

http://www.w3.org/2001/XMLSchema#string

Weiwei Gao

http://www.w3.org/2001/XMLSchema#string

Yiyin Tai

http://www.w3.org/2001/XMLSchema#string

P2860

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Role of CD47 as a marker of self on red blood cells

Regulation of interferon-gamma during innate and adaptive immune responses

Vaccines for tumour prevention

Nanoparticle therapeutics: an emerging treatment modality for cancer

Nanocarriers as an emerging platform for cancer therapy

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions

Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.

Targeting of drugs and nanoparticles to tumors.

P304

2181-2188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NL500618U

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261182463

http://www.w3.org/2001/XMLSchema#string

P698

24673373

http://www.w3.org/2001/XMLSchema#string

P921

P932

3985711

http://www.w3.org/2001/XMLSchema#string